Medicines Related Outcomes projects
Predicting acute asthma events in Aotearoa New Zealand using a machine-learning approach
Asthma is one of the most common long-term conditions in New Zealand, affecting 1 in 5 children and 1 in 8 adults. Deaths from asthma and other lung diseases remains the third leading cause of death...
COVID-19 risk communication
In the absence of a vaccine, all the public health recommendations to protect the health of the public relate to human behaviours. In response to this, a group of 100 researchers from over 33...
Community pharmacy intervention to reduce reliever overuse and over-reliance
Overuse of short-acting beta2-agonists (SABA) increases the risk of asthma attacks. Despite the risks associated with SABA overuse, SABA over-reliance and overuse remains common. One of the key...
Trends in survival following dementia diagnosis, 2000-2018: a multinational cohort study from eight developed jurisdictions
This international study examines the length of survival and trends in relative mortality risk following a first record of dementia diagnosis in eight countries. The aim is to determine the burden...
Trends in high-risk medication use across four countries: Hong Kong, New Zealand, United Kingdom and Australia
This interdisciplinary project across Pharmacy, Psychiatry, Pharmacoepidemiology, and Primary Care and Public Health, aims to characterise the patterns and temporal trends in the global prescribing...
Impact of smoke from the Australia Bushfires on asthma
Between July 2019 and March 2020, Australia experienced an unprecedented number of bushfires known as the Black Summer Bushfires, particularly affecting populations in New South Wales, Queensland,...